Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (167)	3/18/1998 10:35:00 PM
From: scaram(o)uche	Respond to of 337

Richard: Stevens et al. used the magic word.... pharmacogenomics. VGI is going to bust their butts to make Clinical Partners look good to Roche, Glaxo, Gilead, Agouron, Merck, etc., etc., and Clinical Partners has to be hoping that the VGI relationship will cement and expand their relationships with insurance companies. I don't look at the revenues that might accrue from this, and I really doubt that they are significant. To me, this is a route to patients and to getting virtually all decision-makers on the same page. Damn smart of Stevens et al. Absolutely brilliant of CP's management. I'll look forward to hearing that the Letter of Understanding has transformed into a firm deal. Of interest..... systemsplus.com From the release..... "The agreement .... commits the two companies to jointly develop HIV managed care initiatives through payor networks based on VGI's HIV genotyping system." Cheers! Rick